Domestic bevacizumab, or bevacizumab injection, is a drug used for the treatment of metastatic colorectal cancer and other diseases, and needs to be used according to medical advice. Bevacizumab injection can reduce microvascular growth and inhibit the progress of metastatic disease, combined with 5-fluorouracil for metastatic colorectal cancer; combined with platinum for the treatment of inoperable resectable advanced, recurrent or metastatic non-squamous cell, non-small cell lung cancer. Adverse reactions such as gastrointestinal perforation, bleeding (including pulmonary hemorrhage/hemoptysis), arterial thromboembolism, hypertension, fatigue or malaise, abdominal pain, diarrhea, febrile neutropenia, leukopenia, neutropenia, thrombocytopenia, and other adverse reactions have been seen with bevacizumab injection. This product is contraindicated in persons with known hypersensitivity to any of the components of the drug, Chinese hamster ovary cell products, other recombinant human or humanized antibodies. The use of this product for the treatment of disease need to be under the guidance of a doctor reasonable use of medication, not self-medication.